Formaldehyde induces neurotoxicity to PC12 cells involving inhibition of paraoxonase-1 expression and activity

Clinical and Experimental Pharmacology and Physiology

Volumn 38, Issue 4, 2011, Pages 208-214

  Tang, Xiao Qing ^a   Ren, Yan Kai ^a   Chen, Rong Qian ^a   Zhuang, Yuan Yuan ^a   Fang, Heng Rong ^a   Xu, Jin Hua ^a   Wang, Chun Yan ^a   Hu, Bi ^a  

^a UNIVERSITY OF SOUTH CHINA   (China)

Author keywords

Bcl 2; Cytochromec; Formaldehyde; Neurotoxicity; Paraoxonase 1; Reactive oxygen species

Indexed keywords

ARYLDIALKYLPHOSPHATASE 1; CARBOSTYRIL; CYTOCHROME C; FORMALDEHYDE; HYDROGEN SULFIDE; LACTATE DEHYDROGENASE; PROTEIN BCL 2; QUINOLINE DERIVATIVE; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL STRAIN; CONTROLLED STUDY; CYTOTOXICITY; DOWN REGULATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME RELEASE; NERVE CELL NECROSIS; NEUROTOXICITY; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; RAT;

ANIMALS; APOPTOSIS; ARYLDIALKYLPHOSPHATASE; BCL-ASSOCIATED DEATH PROTEIN; CARBOXYLIC ESTER HYDROLASES; CELL LINE, TUMOR; CYTOCHROMES C; DOWN-REGULATION; FORMALDEHYDE; HYDROGEN SULFIDE; HYDROXYQUINOLINES; NEURONS; NEUROTOXICITY SYNDROMES; OXIDATIVE STRESS; PC12 CELLS; RATS; REACTIVE OXYGEN SPECIES; RESPIRATORY HYPERSENSITIVITY;

EID: 79953066022     PISSN: 03051870     EISSN: 14401681     Source Type: Journal    
DOI: 10.1111/j.1440-1681.2011.05485.x     Document Type: Article

References (54)

1. Franklin P, Dingle P, Stick S. Raised exhaled nitric oxide in healthy children is associated with domestic formaldehyde levels. Am. J. Respir. Crit. Care Med. 2000; 161: 1757-9.
2. Luo W, Li H, Zhang Y, Ang CY. Determination of formaldehyde in blood plasma by high-performance liquid chromatography with fluorescence detection. J. Chromatogr. B Biomed. Sci. Appl. 2001; 753: 253-7.
3. Lyles GA. Mammalian plasma and tissue-bound semicarbazide-sensitive amine oxidases: Biochemical, pharmacological and toxicological aspects. Int. J. Biochem. Cell Biol. 1996; 28: 259-74.
4. Yu PH, Cauglin C, Wempe KL, Gubisne-Haberle D. A novel sensitive high-performance liquid chromatography/electrochemical procedure for measuring formaldehyde produced from oxidative deamination of methylamine and in biological samples. Anal. Biochem. 2003; 318: 285-90.
5. Nilsson JA, Zheng X, Sundqvist K et al. Toxicity of formaldehyde to human oral fibroblasts and epithelial cells: Influences of culture conditions and role of thiol status. J. Dent. Res. 1998; 77: 1896-903.
6. Pitten FA, Kramer A, Herrmann K, Bremer J, Koch S. Formaldehyde neurotoxicity in animal experiments. Pathol. Res. Pract. 2000; 196: 193-8.
7. Lu Z, Li CM, Qiao Y, Yan Y, Yang X. Effect of inhaled formaldehyde on learning and memory of mice. Indoor Air 2008; 18: 77-83.
8. Ahmed S, Tsukahara S, Tin Tin Win S et al. Effects of low-level formaldehyde exposure on synaptic plasticity-related gene expression in the hippocampus of immunized mice. J. Neuroimmunol. 2007; 186: 104-11.
9. Kilburn KH. Neurobehavioral impairment and seizures from formaldehyde. Arch. Environ. Health 1994; 49: 37-44.
10. Aslan H, Songur A, Tunc AT et al. Effects of formaldehyde exposure on granule cell number and volume of dentate gyrus: A histopathological and stereological study. Brain Res. 2006; 1122: 191-200.
11. Zararsiz I, Kus I, Akpolat N, Songur A, Ogeturk M, Sarsilmaz M. Protective effects of omega-3 essential fatty acids against formaldehyde-induced neuronal damage in prefrontal cortex of rats. Cell Biochem. Funct. 2006; 24: 237-44.
12. Zararsiz I, Kus I, Ogeturk M et al. Melatonin prevents formaldehyde-induced neurotoxicity in prefrontal cortex of rats: An immunohistochemical and biochemical study. Cell Biochem. Funct. 2007; 25: 413-18.
13. Yu PH. Involvement of cerebrovascular semicarbazide-sensitive amine oxidase in the pathogenesis of Alzheimer's disease and vascular dementia. Med. Hypotheses 2001; 57: 175-9.
14. Unzeta M, Sole M, Boada M, Hernandez M. Semicarbazide-sensitive amine oxidase (SSAO) and its possible contribution to vascular damage in Alzheimer's disease. J. Neural. Transm. 2007; 114: 857-62.
15. Jiang ZJ, Richardson JS, Yu PH. The contribution of cerebral vascular semicarbazide-sensitive amine oxidase to cerebral amyloid angiopathy in Alzheimer's disease. Neuropathol. Appl. Neurobiol. 2008; 34: 194-204.
16. Gurel A, Coskun O, Armutcu F, Kanter M, Ozen OA. Vitamin E against oxidative damage caused by formaldehyde in frontal cortex and hippocampus: Biochemical and histological studies. J. Chem. Neuroanat. 2005; 29: 173-8.
17. Zhou DX, Qiu SD, Zhang J, Tian H, Wang HX. The protective effect of vitamin E against oxidative damage caused by formaldehyde in the testes of adult rats. Asian J. Androl. 2006; 8: 584-8.
18. Kovacic P, Somanathan R. Dermal toxicity and environmental contamination: Electron transfer, reactive oxygen species, oxidative stress, cell signaling, and protection by antioxidants. Rev. Environ. Contam. Toxicol. 2010; 203: 119-38.
19. Maiese K, Chong ZZ, Hou J, Shang YC. Oxidative stress: Biomarkers and novel therapeutic pathways. Exp. Gerontol. 2010; 45: 217-34.
20. Aviram M, Rosenblat M. Paraoxonases and cardiovascular diseases: Pharmacological and nutritional influences. Curr. Opin. Lipidol. 2005; 16: 393-9.
21. Ng CJ, Shih DM, Hama SY, Villa N, Navab M, Reddy ST. The paraoxonase gene family and atherosclerosis. Free Radic. Biol. Med. 2005; 38: 153-63.
22. Aviram M, Billecke S, Sorenson R et al. Paraoxonase active site required for protection against LDL oxidation involves its free sulfhydryl group and is different from that required for its arylesterase/paraoxonase activities: Selective action of human paraoxonase allozymes Q and R. Arterioscler. Thromb. Vasc. Biol. 1998; 18: 1617-24.
23. Aviram M, Rosenblat M, Bisgaier CL, Newton RS, Primo-Parmo SL, La Du BN. Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase. J. Clin. Invest. 1998; 101: 1581-90.
24. Rozenberg O, Shih DM, Aviram M. Paraoxonase 1 (PON1) attenuates macrophage oxidative status: Studies in PON1 transfected cells and in PON1 transgenic mice. Atherosclerosis 2005; 181: 9-18.
25. Tavori H, Aviram M, Khatib S et al. Human carotid atherosclerotic plaque increases oxidative state of macrophages and low-density lipoproteins, whereas paraoxonase 1 (PON1) decreases such atherogenic effects. Free Radic. Biol. Med. 2009; 46: 607-15.
26. Ng DS, Chu T, Esposito B, Hui P, Connelly PW, Gross PL. Paraoxonase-1 deficiency in mice predisposes to vascular inflammation, oxidative stress, and thrombogenicity in the absence of hyperlipidemia. Cardiovasc. Pathol. 2008; 17: 226-32.
27. Rozenberg O, Rosenblat M, Coleman R, Shih DM, Aviram M. Paraoxonase (PON1) deficiency is associated with increased macrophage oxidative stress: Studies in PON1-knockout mice. Free Radic. Biol. Med. 2003; 34: 774-84.
28. Zhang C, Peng W, Jiang X et al. Transgene expression of human PON1 Q in mice protected the liver against CCl4-induced injury. J. Gene Med. 2008; 10: 94-100.
29. Bjorling E, Lindskog C, Oksvold P et al. A web-based tool for in silico biomarker discovery based on tissue-specific protein profiles in normal and cancer tissues. Mol. Cell Proteomics 2008; 7: 825-44.
30. Leduc V, Theroux L, Dea D, Robitaille Y, Poirier J. Involvement of paraoxonase 1 genetic variants in Alzheimer's disease neuropathology. Eur. J. Neurosci. 2009; 30: 1823-30.
31. Gugliucci A, Lunceford N, Kinugasa E, Ogata H, Schulze J, Kimura S. Acrolein inactivates paraoxonase 1: Changes in free acrolein levels after hemodialysis correlate with increases in paraoxonase 1 activity in chronic renal failure patients. Clin. Chim. Acta 2007; 384: 105-12.
32. Wang S, Hu CP, Jiang DJ et al. All-trans retinoic acid inhibits cobalt chloride-induced apoptosis in PC12 cells: Role of the dimethylarginine dimethylaminohydrolase/asymmetric dimethylarginine pathway. J. Neurosci. Res. 2009; 87: 1938-46.
33. Duan WG, Shang J, Jiang ZZ et al. Rho kinase inhibitor Y-27632 down-regulates norepinephrine synthesis and release in PC12 cells. Basic Clin. Pharmacol. Toxicol. 2009; 104: 434-40.
34. Li R, Kong Y, Ladisch S. Nerve growth factor-induced neurite formation in PC12 cells is independent of endogenous cellular gangliosides. Glycobiology 1998; 8: 597-603.
35. Gan KN, Smolen A, Eckerson HW, La Du BN. Purification of human serum paraoxonase/arylesterase. Evidence for one esterase catalyzing both activities. Drug Metab. Dispos. 1991; 19: 100-6.
36. Nicholls DG, Budd SL. Mitochondria and neuronal survival. Physiol. Rev. 2000; 80: 315-60.
37. Brunelle JK, Letai A. Control of mitochondrial apoptosis by the Bcl-2 family. J. Cell Sci. 2009; 122: 437-41.
38. Nakao A, Sugimoto R, Billiar TR, McCurry KR. Therapeutic antioxidant medical gas. J. Clin. Biochem. Nutr. 2009; 44: 1-13.
39. Calvert JW, Coetzee WA, Lefer DJ. Novel insights into hydrogen sulfide - mediated cytoprotection. Antioxid. Redox Signal. 2010; 12: 1203-17.
40. Song MS, Baker GB, Dursun SM, Todd KG. The antidepressant phenelzine protects neurons and astrocytes against formaldehyde-induced toxicity. J. Neurochem. 2010; 114: 1405-13.
41. Lim SK, Kim JC, Moon CJ, Kim GY, Han HJ, Park SH. Formaldehyde induces apoptosis through decreased Prx 2 via p38 MAPK in lung epithelial cells. Toxicology 2010; 271: 100-6.
42. Menze MA, Fortner G, Nag S, Hand SC. Mechanisms of apoptosis in Crustacea: What conditions induce versus suppress cell death? Apoptosis 2010; 15: 293-312.
43. Tsukahara S, Yamamoto S, Tin Tin Win S et al. Inhalation of low-level formaldehyde increases the Bcl-2/Bax expression ratio in the hippocampus of immunologically sensitized mice. Neuroimmunomodulation 2006; 13: 63-8.
44. Circu ML, Aw TY. Reactive oxygen species, cellular redox systems, and apoptosis. Free Radic. Biol. Med. 2010; 48: 749-62.
45. Monaghan P, Metcalfe NB, Torres R. Oxidative stress as a mediator of life history trade-offs: Mechanisms, measurements and interpretation. Ecol. Lett. 2009; 12: 75-92.
46. Alexandre J, Batteux F, Nicco C et al. Accumulation of hydrogen peroxide is an early and crucial step for paclitaxel-induced cancer cell death both in vitro and in vivo. Int. J. Cancer 2006; 119: 41-8.
47. Chan WH, Wu HJ, Hsuuw YD. Curcumin inhibits ROS formation and apoptosis in methylglyoxal-treated human hepatoma G2 cells. Ann. N Y Acad. Sci. 2005; 1042: 372-8.
48. Pirlich M, Kiok K, Sandig G, Lochs H, Grune T. Alpha-lipoic acid prevents ethanol-induced protein oxidation in mouse hippocampal HT22 cells. Neurosci. Lett. 2002; 328: 93-6.
49. Rayner BS, Duong TT, Myers SJ, Witting PK. Protective effect of a synthetic anti-oxidant on neuronal cell apoptosis resulting from experimental hypoxia re-oxygenation injury. J. Neurochem. 2006; 97: 211-21.
50. Hildeman DA, Mitchell T, Aronow B, Wojciechowski S, Kappler J, Marrack P. Control of Bcl-2 expression by reactive oxygen species. Proc. Natl Acad. Sci. USA 2003; 100: 15035-40.
51. Moungjaroen J, Nimmannit U, Callery PS et al. Reactive oxygen species mediate caspase activation and apoptosis induced by lipoic acid in human lung epithelial cancer cells through Bcl-2 down-regulation. J. Pharmacol. Exp. Ther. 2006; 319: 1062-9.
52. Schafer FQ, Buettner GR. Redox environment of the cell as viewed through the redox state of the glutathione disulfide/glutathione couple. Free Radic. Biol. Med. 2001; 30: 1191-212.
53. Aviram M, Rosenblat M, Billecke S et al. Human serum paraoxonase (PON 1) is inactivated by oxidized low density lipoprotein and preserved by antioxidants. Free Radic. Biol. Med. 1999; 26: 892-904.
54. Rozenberg O, Shiner M, Aviram M, Hayek T. Paraoxonase 1 (PON1) attenuates diabetes development in mice through its antioxidative properties. Free Radic. Biol. Med. 2008; 44: 1951-9.